Can WHO’s pandemic instrument be designed to address a wider range of pandemic threats? The Policy Accelerator advises on how the pandemic instrument could be made more comprehensive.
Antimicrobial resistance has generated an unprecedented amount of global attention since the launch of the Global Action Plan on AMR. Our research explores how global commitments on AMR have changed and adapted since 2015.
The Paris Agreement successfully mobilized collective action to protect a shared global common-pool resource and mitigate and adapt to the impacts of climate change. What are the takeaways for managing AMR?
How has the COVID-19 pandemic impacted antimicrobial use (AMU) and antimicrobial resistance (AMR)? As more data become available, the picture is becoming clearer.
The Global Strategy Lab was designated as the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance in 2019.
The Global Strategy Lab is a proud founding member of INAMRSS, a network dedicated to social science research and policy on antimicrobial resistance.
What do researchers from the disciplines of law, anthropology, history, public health, public policy, economics, and veterinary medicine contribute to the debate about addressing AMR in the pandemic instrument? Explore this special issue of the Journal of Law, Medicine and Ethics.
A partnership of world leading social science research centres has come together to develop global governance strategies to tackle AMR. This partnership brings together experts in economics, ethics, evaluation, evidence synthesis, gender analysis, law, political science, and veterinary science.
In many countries, the COVID-19 pandemic thrust Chief Medical Officers of Health (CMOHs) into the spotlight and revealed key misunderstandings in public discourse about the roles of senior public health leadership. Despite their critical role in providing information and influencing public behavior during emergencies, little is known about how they balance competing scientific and political priorities in their work.
In Canada, the need for organs for transplantation far exceeds the donated supply, despite the long-term goal of the organ donation and transplantation (ODT) system is to achieve the balance between donated organs and transplant patient needs. To address some of the challenges with the current system, GSL’s Public Health Institutions team has engaged with stakeholders and system leaders to provide a series of options for an improved ODT governance structure in Canada, ultimately improving population health outcomes.